522 related articles for article (PubMed ID: 28619428)
41. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
42. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
Mehta LR; Samuelsson MK; Kleiner AK; Goodman AD; Anolik JH; Looney RJ; Schwid SR
Mult Scler; 2008 Apr; 14(3):425-7. PubMed ID: 18208886
[TBL] [Abstract][Full Text] [Related]
43. Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
Masi G; Cioni C; Arrigucci U; Cerase A; Annunziata P
Neurol Sci; 2015 Oct; 36(10):1925-7. PubMed ID: 26050233
[No Abstract] [Full Text] [Related]
44. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
45. Neuromyelitis optica preceded by brain demyelinating episode.
Amemiya S; Hamamoto M; Kumagai T; Ueda M; Katayama Y; Tanaka K
J Neuroimaging; 2009 Jul; 19(3):263-5. PubMed ID: 18681925
[TBL] [Abstract][Full Text] [Related]
46. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
47. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
[TBL] [Abstract][Full Text] [Related]
48. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
49. [Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Hervás-García JV; Grau-López L; Doménech-Puigcerver S; Ramo-Tello C
Rev Neurol; 2014 Jan; 58(1):20-4. PubMed ID: 24343537
[TBL] [Abstract][Full Text] [Related]
50. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ
Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202
[TBL] [Abstract][Full Text] [Related]
51. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
Wu L; Yang Y; Huang DH; Wu WP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891
[TBL] [Abstract][Full Text] [Related]
52. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
[TBL] [Abstract][Full Text] [Related]
53. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
[TBL] [Abstract][Full Text] [Related]
54. Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica.
Lu Z; Qiu W; Zou Y; Lv K; Long Y; You W; Zheng X; Hu X
J Neurol Sci; 2010 Jun; 293(1-2):92-6. PubMed ID: 20346462
[TBL] [Abstract][Full Text] [Related]
55. Neuromyelitis optica: a case report.
Chia WC; Wang JN; Lai MC
Pediatr Neonatol; 2010 Dec; 51(6):347-52. PubMed ID: 21146800
[TBL] [Abstract][Full Text] [Related]
56. Neuromyelitis optica mimics the morphology of spinal cord tumors.
Erol İ; Özkale M; Savaş T; Alkan Ö; Çekinmez M; Erbay A
Turk J Pediatr; 2016; 58(3):309-314. PubMed ID: 28266199
[TBL] [Abstract][Full Text] [Related]
57. Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Sudulagunta SR; Sodalagunta MB; Khorram H; Sepehrar M; Gonivada J; Noroozpour Z; Prasad N
Ger Med Sci; 2015; 13():Doc22. PubMed ID: 26633965
[TBL] [Abstract][Full Text] [Related]
58. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
59. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
Nakashima I
Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
[TBL] [Abstract][Full Text] [Related]
60. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
